Serum creatinine is a very common tool of renal assessment in diabetic nephropathy. Specially due to its availably and costeffectiveness, serum creatinine has been a popular choice among the clinicians even in rural areas. Also, the staging of diabetic nephropathy is done on the basis of eGFR which is calculated mainly with serum creatinine level. Sometimes, clinicians, even overlook the other investigations, such as urine routine examinations or ultra sonogram of kidney, when the serum creatinine level is within normal limit. This study aims at observation of existing correlation between serum creatinine and urine albumin in diabetic nephropathy patients. This cross sectional observational study has been conducted on 50 patients in a period of 6 months in the medicine department of Dhaka Medical College Hospital. 50 diabetic patients admitted to Dhaka Medical College Hospital were enrolled in this study after fulfilling inclusion and exclusion criteria. Among the total 50 patients, 34 patients were diagnosed on the basis of microalbuminuria and the rest had raised urinary total protein. No correlation was found between serum creatinine and urine albumin or urine total protein. Staging of the kidney disease was done according to eGFR (calculated by MDRD equation). Only 41.37% of the patients with microalbuminuria, showed eGFR consistent with its staging while 31.5% of the patients with proteinuria showed respective expected eGFR. The rest of the patient's eGFR was inconsistent with the staging. And the difference between the mean serum creatinine in two groups was insignificant. This study has shown that, the serum creatinine has no linear correlation with urinary albumin in diabetic nephropathy patients. So, commonly used serum creatinine based formula to calculate the eGFR can misinterpret the staging of the disease which can delay the appropriate treatment thereafter. Keywords: Diabetic Nephropathy, Proteinuria, Microalbuminuria, Serum Creatinine Introduction:
Introduction:
The word "Diabetes" means "passing through", referring to the polyuria, a symptom historically present on those affected by the disease 1 . About 30% of diabetic patients develops nephropathy after 20 years of diagnosis 2 . The disease is progressive and may cause death in two or three years after the initial diagnosis and is more frequent in men 3 .
The prevalence of diabetes and nephropathy is high in the world as well as in Bangladesh. Based on 2002 US data, diabetes is the cause of renal disease in 44% to 45% of ESRD (end stage renal disease) cases worldwide 3 .About 5.6 % of the affected population thought to be leading to ESRD and being the cause of morbidity and mortality among diabetic patients in Bangladesh 4 . The renal hemodynamic abnormality is similar in type 1 and type 2 diabetes 5 . Diabetic nephropathy has several distinct stages of development. First stage is "Glomerular hyperfiltration". Here functional changes occur in the nephron at the level of the glomerulus, including glomerular hyperfiltration and hyperperfusion, before the onset of any measurable clinical changes (eGFR >90 ml/min/1.73m 2 ).The next stage is the "Normal Albuminuria" where the GFR remains elevated but urine albumin expelling is normal and glomerular basement membrane (GBM) thickens as mesangium matrix increases (eGFR 60-89 ml/min/1.73m 2 ) 6 . In the third stage, named as "Incipient stage", there is microalbuminuria ; which is the first laboratory marker of the disease. In this stage, the blood pressure will slightly rise (eGFR 30-59ml/min/1.73m 2 Various MDRD equations have been published; however, the most widely used equation by the health care community is the abbreviated (fourvariable) MDRD equation, which has been reformulated to be used with a standardized serum creatinine assay .It uses age, the inverse of serum creatinine, gender, and race (African American versus non-African American) 11 . However, there are few pitfalls of this equation. Firstly, age-and gender-associated differences in creatinine production are proportional to muscle mass, and creatinine generation can vary significantly in a given individual over time when muscle mass changes 12, 13 . Creatinine is small, circulates unbound to plasma proteins, and is freely filtered at the glomerulus but undergoes tubular secretion into the urinary space 14 . Tubular secretion of creatinine is not constant and varies, not only within an individual, but between individuals. Further, the proportion of total renal creatinine excretion due to tubular secretion increases with decreasing renal function. Also several substances can interfere with laboratory measurements of creatinine, eg.-Glucose, uric acid, ketones, plasma proteins, and cephalosporins etc,. 15, 16 For all these reasons, serum creatinine based equations are not truly reliable to measure GFR. Either we should measure GFR directly or we need an exact relation between these two markers.
Methods & Materials:
This cross sectional observational study has been conducted on 50 diabetic patients admitted to medicine department of Dhaka Medical College Hospital. Patients were included in this study after fulfilling inclusion and exclusion criteria in a period of 6 months. After selection, data were collected by structured questionnaire. Then 24 hour urinary total protein, urine for microalbumin, complete blood count, fasting blood sugar , two hours postprandial blood sugar, HbA1C, serum creatinine report were collected and analyzed it with the help of SPSS 16.0 MSexcel.
Inclusion criteria include diabetic nephropathy evidenced by microalbuminuria or proteinuria.
Exclusion criteria were: patient receiving ACE inhibitor, ARB, Calcium Channel Blocker, Hypertension, Pregnancy,UTI,any other causes of proteinuria;egVasculitis, Heart Failure, Malignancy,etc. and non-cooperative patient.
Results
Among total 50 patients, 34 patients were included on the basis of urine microalbumin and named as group 1 and the rest 16 patients were included due to protienuria above the physiological range, they were named as group 2. The serum creatinine was compared with the urine microalbumin and total protein respectively. But no correlation was found (reflected by nonsignificant r value ( figure 6 and  figure 7) . Then, the estimated GFR (eGFR) was measured according to the MDRD equation individualy. The eGFR was used to determine the corresponding staging of the patients ( figure 8 and  figure 10 ). According to the definition, staging was compared with the urine protein excretion. Then it was found that, among the group 1 patients, 68% showed eGFR consistent with its staging (figure 9) while 62% of the patients of the group 2 showed respective expected eGFR (figure 11). Mean serum creatinine value of both groups were calculated and compared. The difference of the mean serum creatinine was insignificant (figure 12). The chart shows that most of the patients were in between the age group of 51 to 70. The mean age of the population is 62 years. The pie chart shows that 54 % of the population was male while the rest 46% patients were female, which reveals that both sexes are more or less equally affected by the disease. No apparent correlation was observed between Serum Cereatinine and UTP in the study population. Random distribution of the data points rules out any liner correlation between these two parameter among the 16 patients of Group 2.The value of r is not significant.
Figure 4: Correlation between Serum Creatinine and Urine Microalbumin
No significant correlation was observed between Serum Cereatinine and Urine Microalbumin in the study population. Absence of any positive correlation rules out any possibility of linerity betrween these two parameters among 34 patients of group 1. The value of r is not significant. So, the diagram shows that 68% of the populations belong to the stage 3 and the rest are scattered in different stages. The chart reveals that the difference of serum creatinine in two groups is insignificant.
Discussion:
This cross-sectional observational study was carried out on 50 diabetic patients, who fulfilled the inclusion criteria, with an aim to observe the correlation between serum creatinine and urine albumin of diabetic nephropathy patients. The earliest indicator of nephropathy is microalbuminuria. Microalbuminuria means (30-300) mg of albumin are excreted through urine per day. It is considered as the indicator of stage 3 kidney disease. In stage 3 kidney disease the calculated GFR (eGFR) should be between (30-59) ml/min. As the disease progresses, the urine albumin excretion increases over time. In stage 4, the urine albumin excretion is more than 0.5g/24hours, where the eGFR normally ranges between 15 to 30 ml/min.
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Among the study population, the mean age was about 62 years ( Figure 1 ). The male and female ratio was near about equal. 54% of the patients were male whereas 46% of the patients were female. Among these 50 patients, 34 patients were included as there was microalbuminuria (Group 1). And the rest 16 patients were included because they had protenuria (Group 2). Figure 3 and 4 reflect that serum creatinine has no virtual correlation with UTP and urine microalbumin respectively as evident by the scattered plot table showing that and the 'r' value is non-significant. Then we calculated the eGFR using MDRD equation. Later group 1 & 2 patients were distributed to different stages of diabetic nephropathy according to their eGFR ( Figure 5 & Figure 7 ). Here almost 68% population belong to the stage 3( Figure 6 ).The rest belongs to stage 1, 2, and 4. Similarly, 62% of population of Group-2 was in the stage 4. Rests were in different groups which is non-coherent with their urine protein excretion ( Figure  8 ). Thus the study reveals that serum Creatinine is not a good reflector of the staging of the diabetic nephropathy as well as the creatinine based commonly used MDRD equation. It is supported by the study done by Pradeep Kumar Dabla in 201011. He mentioned that this equation has recognized limitations, including a tendency to significantly underestimate higher levels of GFR12. Additionally, Parving and colleagues demonstrated that in type 2 diabetic subjects with macroalbuminuria, eGFR had a poor sensitivity for GFR values < 60 mL/min per 1.73 m2.13 There are more reports available those show that variation in calibration of the creatinine assay has an adverse impact on the performance of eGFR to estimate GFR, particularly at low levels of serum creatinine15,16. So, only Serum creatinine is not enough for staging the diabetic nephropathy and not even for follow up.
To support this evidence, we calculated the mean serum creatinine of both of the groups (Figure 9 ). The mean serum creatinine of group 1 is 129.062 mmol/L with a standard daviation of 53.78 while group 2 has a mean serum creatinine 175.94 mmol/L with a standard daviation of 71.30. We calculated the 'P' value and it was insignificant. So, both of the groups have no significant difference in serum creatinine value but they have a pretty different level of urinary protein excretion. It again points that serum creatinine is not a reliable marker for diabetic nephropathy.
Conclusion:
Diabetic nephropathy is a common disease in our country. It is, independently, associated with higher mortality and morbidity. Early detection of the disease will help us to formulate a plan for individual patient management. This study showed that if any diabetic patient is screened or a diabetic nephropathy patient is followed up by serum creatinine only, there is a good possibility to miss the proper diagnosis. As it does not reflect the proper staging all the time. All these findings of the study is statistically important to point towards setting an important criteria about correlation between serum creatinine and urine protein. Future more researches should be directed to set up such guideline and also how urine protein can be calculated easily even in rural areas.
